Related Experiment Video
Updated: Jul 5, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Acremonium spp. peritonitis in an infant
Tanil Kendirli1, Ergin Ciftçi, Mesiha Ekim
1Pediatric Intensive Care Unit, Ankara University School of Medicine, Ankara, Turkey. tanilkendirli@hotmail.com
Abstract:
Fungal peritonitis is a rare but serious complication in children on peritoneal dialysis. Clinical presentation of fungal peritonitis is similar to bacterial peritonitis and Candida spp. are the most common agent. Fungal peritonitis has been usually associated with high morbidity, mortality and its treatment is difficult. In this report, we present an infant with Acremonium spp. peritonitis. A 7-month-old boy with Down syndrome, congenital heart disease, pulmonary hypertension and congestive heart failure required peritoneal dialysis for his persistent pulmonary oedema and symptomatic hyponatremia. Acremonium spp. peritonitis developed while he was on extended spectrum antibiotics and fluconazole. The patient was successfully treated with peritoneal dialysis catheter removal and liposomal amphotericin B. The case was presented to draw attention to a rare cause of peritonitis -Acremonium spp. - in a paediatric patient.
Insights
Fungal peritonitis is a serious complication in children undergoing peritoneal dialysis. This case highlights Acremonium spp. as a rare cause, successfully treated with catheter removal and liposomal amphotericin B.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Medical Mycology
Background:
- Fungal peritonitis is a rare but severe complication in pediatric patients undergoing peritoneal dialysis (PD).
- Candida species are the most common fungal agents, often leading to significant morbidity and mortality.
- Treatment can be challenging, necessitating a high index of suspicion for early diagnosis and management.
Observation:
- A 7-month-old infant with Down syndrome, congenital heart disease, pulmonary hypertension, and congestive heart failure required PD for edema and hyponatremia.
- The infant developed Acremonium spp. peritonitis despite receiving broad-spectrum antibiotics and fluconazole.
- This presentation underscores the potential for non-Candida fungal infections in immunocompromised pediatric patients on PD.
Findings:
- Acremonium spp. was identified as the causative agent of peritonitis in this infant.
- Successful treatment involved the removal of the peritoneal dialysis catheter and administration of liposomal amphotericin B.
- This case demonstrates an effective therapeutic strategy for a rare fungal peritonitis etiology.
Implications:
- Highlights Acremonium spp. as a potential, albeit rare, cause of fungal peritonitis in pediatric PD patients.
- Emphasizes the need for considering a broader range of fungal pathogens beyond Candida in refractory or unusual cases.
- Suggests that aggressive management, including catheter removal and targeted antifungal therapy, is crucial for favorable outcomes in pediatric fungal peritonitis.
Related Concept Videos
Intestinal Obstruction II: Pathophysiology
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Bacterial Meningitis I: Introduction
Pneumonia III: Complications and Assessment

